Angiofibroma
📧 Sign up to get email alerts when something new happens for Angiofibroma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Hyftor (sirolimus) — Plusultra pharma GmbH
Sirolimus (Hyftor) from Plusultra pharma GmbH has been authorised for use in angiofibroma and tuberous sclerosis, designated as an orphan me…
-
EMA approval · 2025-07-04EMA Authorised: Hyftor (sirolimus) — Plusultra pharma GmbH
The EMA authorised Hyftor (sirolimus) by Plusultra pharma GmbH for angiofibroma and tuberous sclerosis complex with orphan medicine status.